| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net sales | 267,558 | 255,467 | 250,519 | 239,940 |
| Cost of sales | 172,105 | 162,354 | 162,351 | 154,579 |
| Gross margin | 95,453 | 93,113 | 88,168 | 85,361 |
| Selling expenses | 19,092 | 19,300 | 16,926 | 15,557 |
| Research and development expenses | 4,496 | 4,300 | 4,662 | 4,329 |
| General and administrative expenses | 17,286 | 18,071 | 15,565 | 17,483 |
| Total operating expenses | 40,874 | 41,671 | 37,153 | 37,369 |
| Earnings from operations | 54,579 | 51,442 | 51,015 | 47,992 |
| Interest expense, net | -2,629 | -2,766 | -2,924 | -4,071 |
| Other (income) expense, net | 94 | 335 | -151 | -28 |
| Total other (income) expenses | -2,535 | -2,431 | -3,075 | -4,099 |
| Earnings before income tax expense | 52,044 | 49,011 | 47,940 | 43,893 |
| Income tax expense | 11,755 | 10,733 | 10,887 | 10,056 |
| Net earnings | 40,289 | 38,278 | 37,053 | 33,837 |
| Net earnings per common share - basic (in dollars per share) | 1.25 | 1.18 | 1.14 | 1.05 |
| Net earnings per common share - diluted (in dollars per share) | 1.24 | 1.17 | 1.13 | 1.03 |
| Weighted average common shares - basic (in shares) | 32,265,000 | 32,354,000 | 32,440,000 | 32,373,000 |
| Weighted average common shares - diluted (in shares) | 32,595,000 | 32,682,000 | 32,807,000 | 32,783,000 |
BALCHEM CORP (BCPC)
BALCHEM CORP (BCPC)